ACE inhibitor-induced angioedema.
Publication/Presentation Date
2-1-2012
Abstract
Much has been written about hereditary angioedema (HAE) in recent literature; however, the prevalence of angiotensin-converting enzyme inhibitor-induced angioedema (ACEiIA) far exceeds that of HAE. Similarly, multiple therapies have been developed for HAE, yet no definitive therapy is available for ACEiIA. In this article, we discuss the mechanism, prevalence, pathophysiology, and management of ACEiIA, with focus on newer therapies recently approved for HAE and how they may be effective for ACEiIA.
Volume
12
Issue
1
First Page
72
Last Page
78
ISSN
1534-6315
Published In/Presented At
Vasekar, M., & Craig, T. J. (2012). ACE inhibitor-induced angioedema. Current allergy and asthma reports, 12(1), 72–78. https://doi.org/10.1007/s11882-011-0238-z
Disciplines
Medicine and Health Sciences
PubMedID
22127615
Department(s)
Department of Medicine, Hematology-Medical Oncology Division
Document Type
Article